Prostate cancer is the most commonly diagnosed malignancy in men, and ranks second in mortality rate after lung cancer in the USA. Cancer and benign prostatic hyperplasia (BPH) is an increasing socio-economic burden on the medical care system with increase in life span of males. Prostate cancer is progressive to malignancy, but occurs primarily in two stages. Type I cancers are largely responsive to anti-androgen treatment, but over long periods progress to the type II malignant and untreatable state. Understanding of the progressive transition from type I to type II states is urgently needed to guide diagnosis, prevention and treatment. The hypothesis underlying this continuation project is that the progression from the non-malignant to malignant states is a stepwise disruption of homeostasis mediated by communication between epithelium and stroma of the prostate. The heparin-binding fibroblast growth factor (FGF) family of polypeptides and its receptor (FGF-R) has been firmly implicated in mediation of growth and differentiation within the prostate. The FGF family is an extremely heterogenous three component system-FGF polypeptides, FGF receptor kinase and FGF heparan sulfate proteoglycan. This project will determine the molecular and cellular mechanisms underlying mediation of homeostasis (growth, growth inhibition/death and differentiation) by specific members of the FGF family in prostate and the changes that occur during progression to malignancy. Specifically, the project will determine (1) the specific roles of stromal derived FGF-7 and FGF-10 in instruction of epithelial phenotypes; (2) the time course and sequence of changes in the FGF signaling system during progression of pre-malignant tumor epithelial cells to malignancy; (3) relative roles of the ecto- and intracellular domains of FGFR1 and FGFR2 in the process; (4) role of androgen and its receptor in squamous versus glandular differentiation; (5) structural motifs in FGFR1 and FGFR2 underlying effects on non-malignant and malignant cell phenotypes; (6) impact of changes in specific peri- cellular heparan sulfates; (7) conditions that regulate alternate splicing of the FGFR2 gene. Lastly, the project will employ mouse genetics to test the physiological consequence of FGFR1 and FGFR2 on prostate tumor progression. These results will open up new avenues for early diagnosis of prostate tumor potential for progression, for prevention of progression and for treatment of malignancies targeted to the FGFR signaling system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA059971-11
Application #
6376000
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1993-11-01
Project End
2003-04-30
Budget Start
2001-05-01
Budget End
2002-04-30
Support Year
11
Fiscal Year
2001
Total Cost
$237,388
Indirect Cost
Name
Texas A&M University
Department
Type
Schools of Medicine
DUNS #
City
College Station
State
TX
Country
United States
Zip Code
77845
Liu, Leyuan; Xie, Rui; Nguyen, Susan et al. (2009) Robust autophagy/mitophagy persists during mitosis. Cell Cycle 8:1616-20
Huang, Xinqiang; Yang, Chaofeng; Jin, Chengliu et al. (2009) Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis. Mol Carcinog 48:553-62
Liu, Leyuan; Xie, Rui; Yang, Chaofeng et al. (2009) Dual function microtubule- and mitochondria-associated proteins mediate mitotic cell death. Cell Oncol 31:393-405
Luo, Yongde; Yang, Chaofeng; Jin, Chengliu et al. (2009) Novel phosphotyrosine targets of FGFR2IIIb signaling. Cell Signal 21:1370-8
Zhang, Yongyou; Zhang, Jue; Lin, Yongshun et al. (2008) Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis. Development 135:775-84
Huang, Xinqiang; Yang, Chaofeng; Luo, Yongde et al. (2007) FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver. Diabetes 56:2501-10
Luo, Yongde; Huang, Xinqiang; McKeehan, Wallace L (2007) High yield, purity and activity of soluble recombinant Bacteroides thetaiotaomicron GST-heparinase I from Escherichia coli. Arch Biochem Biophys 460:17-24
Moss, Tijuana N; Vo, Amy; McKeehan, Wallace L et al. (2007) UXT (Ubiquitously Expressed Transcript) causes mitochondrial aggregation. In Vitro Cell Dev Biol Anim 43:139-46
Luo, Yongde; Ye, Sheng; Kan, Mikio et al. (2006) Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb. J Cell Biochem 97:1241-58
Luo, Yongde; Ye, Sheng; Kan, Mikio et al. (2006) Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs. J Biol Chem 281:21052-61

Showing the most recent 10 out of 58 publications